Clinical Trial Update: A Probiotic Strategy for Antipsychotic-induced Metabolic Dysfunction [NA]

View source ↗

Summary

A clinical trial is evaluating a probiotic approach to address metabolic dysfunction caused by antipsychotic treatment in psychosis; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis

Drugs mentioned

• Probiotic formulation

Snippet

Sponsor: University College Cork | Conditions: Psychosis | NA | Status: RECRUITING